1 |
Kalbasi A, Siurala M, Su LL, Tariveranmoshabad M, Picton LK, Ravikumar P, Li P, Lin JX, Escuin-Ordinas H, Da T, Kremer SV, Sun AL, Castelli S, Agarwal S, Scholler J, Song D, Rommel PC, Radaelli E, Young RM, Leonard WJ, Ribas A, June CH, Garcia KC. Potentiating adoptive cell therapy using synthetic IL-9 receptors. Nature 2022;607:360-5. [PMID: 35676488 DOI: 10.1038/s41586-022-04801-2] [Reference Citation Analysis]
|
2 |
Yu S, Li W, Tang L, Fan X, Yao S, Zhang X, Bi Z, Cheng H. Depression in breast cancer patients: Immunopathogenesis and immunotherapy. Cancer Letters 2022;536:215648. [DOI: 10.1016/j.canlet.2022.215648] [Reference Citation Analysis]
|
3 |
Gavali S, Liu J, Li X, Paolino M. Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy. Int J Mol Sci 2021;22:10800. [PMID: 34639141 DOI: 10.3390/ijms221910800] [Reference Citation Analysis]
|
4 |
Zhang L, Chai D, Chen C, Li C, Qiu Z, Kuang T, Parveena M, Dong K, Yu J, Deng W, Wang W. Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors. Front Microbiol 2022;13:946995. [DOI: 10.3389/fmicb.2022.946995] [Reference Citation Analysis]
|